-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $230

Benzinga·04/30/2025 14:16:44
Listen to the news
UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $217 to $230.